INS and metabolic dysfunction-associated steatotic liver disease: Clinical experimental studies on n-3 PUFA dietary supplements (fish oil) showed that n-3 PUFAs have beneficial effects on the liver in NAFLD patients by preventing lipid accumulation, reducing plasma triglyceride levels, and increasing insulin sensitivity [35,36].